BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1713221)

  • 1. Prealbumin in the diagnosis of bronchopulmonary carcinoid tumours.
    Suresh UR; Wilkes S; Hasleton PS
    J Clin Pathol; 1991 Jul; 44(7):573-5. PubMed ID: 1713221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization of prealbumin as a marker for carcinoid tumours.
    Miller ID; Reid WA; Liddle CN; Horne CH
    J Pathol; 1984 Jul; 143(3):199-204. PubMed ID: 6205127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases.
    Bonato M; Cerati M; Pagani A; Papotti M; Bosi F; Bussolati G; Capella C
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(3):201-11. PubMed ID: 1372778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
    Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
    Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
    Srivastava A; Hornick JL
    Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
    Laitinen KL; Soini Y; Mattila J; Pääkkö P
    Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
    Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
    Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
    Ling C; Shen Y
    J Clin Pathol; 2018 Nov; 71(11):1030. PubMed ID: 30154130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
    Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
    Cancer Cytopathol; 2018 Apr; 126(4):236-242. PubMed ID: 29316326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bronchopulmonary carcinoid tumours].
    Rena O; Filosso PL; Ruffini E; Oliaro A
    Minerva Chir; 2002 Aug; 57(4):403-23. PubMed ID: 12145571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of pulmonary carcinoids - ten-year results].
    Vodicka J; Spidlen V; Klecka J; Simanek V; Safranek J; Mukensnabl P
    Zentralbl Chir; 2011 Dec; 136(6):598-603. PubMed ID: 21786224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of various peptides in typical and atypical bronchopulmonary carcinoid tumours.
    al-Saffar N; White A; Moore M; Hasleton PS
    Br J Cancer; 1988 Dec; 58(6):762-6. PubMed ID: 2906252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
    Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
    Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. II. Well-differentiated neuroendocrine carcinomas.
    Warren WH; Memoli VA; Gould VE
    Ultrastruct Pathol; 1984; 7(2-3):185-99. PubMed ID: 6085431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdiagnosis of a typical carcinoid tumor as an adenocarcinoma of the lung: a case report and review of the literature.
    Demirci I; Herold S; Kopp A; Flaßhove M; Klosterhalfen B; Janßen H
    World J Surg Oncol; 2012 Jan; 10():19. PubMed ID: 22269186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustentacular cells in pulmonary neuroendocrine tumours.
    Gosney JR; Denley H; Resl M
    Histopathology; 1999 Mar; 34(3):211-5. PubMed ID: 10217561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.